Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04066296 · ClinicalTrials.gov registry record · Phase 2
Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine
A Phase 2 study of Lumbar Spinal Stenosis, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04066296: Recruiting Phase 2 study of Lumbar Spinal Stenosis, sponsored by University of Colorado, Denver.
NCT04066296 is a Phase 2 study of Lumbar Spinal Stenosis that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 100 participants, below the 664-participant average among 18 other Lumbar Spinal Stenosis trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04066296, a Phase 2 study of Lumbar Spinal Stenosis, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate the benefit of using liposomal bupivicaine in lumbar laminectomies in terms of length of stay, IV narcotic use, 30-day narcotic use, visual analog score (VAS) and 30-day readmissions
Primary Outcome
Length of stay will be measured in hours
Conditions Studied
Interventions
- DRUG Liposomal bupivacaine
Study Locations (1)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-09-08 |
| Est. Completion | 2025-01 |
| Phase | Phase 2 |
What NCT04066296 shows while recruiting
NCT04066296 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 664-participant average among 18 other Lumbar Spinal Stenosis trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Lumbar Spinal Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Liposomal bupivacaine is the first listed.
NCT04066296 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04066296 about?
NCT04066296 is a clinical study titled "Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine". Evaluate the benefit of using liposomal bupivicaine in lumbar laminectomies in terms of length of stay, IV narcotic use, 30-day narcotic use, visual analog score (VAS) and 30-day readmissions
What is the current status of trial NCT04066296?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2019-09-08. Estimated completion is 2025-01.
What conditions does trial NCT04066296 study?
This clinical trial studies the following conditions: Lumbar Spinal Stenosis.
What interventions are being tested in trial NCT04066296?
The interventions under investigation include: Liposomal bupivacaine (DRUG).
Who is sponsoring clinical trial NCT04066296?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04066296 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lumbar Spinal Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04066296's enrollment target sits among peer trials
100 10th of 18 higher than 6 of 18 other Lumbar Spinal Stenosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lumbar Spinal Stenosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
RECRUITING
-
REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain
RECRUITING · NA
-
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
RECRUITING
-
Study Comparing Local/ MAC Anesthesia in Lumbar Decompression
RECRUITING · Early Phase 1
-
Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI